Track topics on Twitter Track topics that are important to you
If you haven’t heard of BioPharm America™, here’s what you need to know: BioPharm America is an international partnering conference with a focus on the life science industry. The conferen...
Johnson & Johnson subsidiary Janssen Biotech has signed a definitive agreement to buy biotechnology company BeneVir Biopharm for a total...Read More... The post Janssen to acquire BeneVir Biopharm...
NewsJanssen will gain Benevir Biopharm's oncolytic immunotherapy platform in the acquisition.
Tot Biopharm has opened its second monoclonal antibody (mAb) production plant in Suzhou Industrial Park, China.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BioPharm/BioTech .MA-Cambridge, BioPharma/BioTech BIOPHARMA/BIOTECH Amgen, In...
Biotechnology company TC BioPharm and Scotia Biologics agreed to work together to develop therapies for cancer and major vira -More-
BeneVir Biopharm, a privately-held biotechnology company in the life science portfolio of the HC2 holding, will be bought by Janssen Biotech, a subsidiary of Johnson & Johnson under a recently sig...
Janssen Biotech has agreed to acquire US-based BeneVir Biopharm, a biopharmaceutical company focused on developing oncolytic immunotherapies for cancer, in a deal worth $1.04bn.
Tumor-specific neoantigens have attracted much attention since they can be used as biomarkers to predict therapeutic effects of immune checkpoint blockade therapy and as potential targets for cancer i...
Staphylococcus aureus persistently colonizes the skin and nasopharynx of approximately 20% to 30% of individuals, with the highest rates in younger children. To avoid clinical problems for carriers an...
Doxorubicin (DOX) has been extensively used to treat a wide range of cancers in free and nanotized form. Nanotization of Doxorubicin (DOX) has alleviated its toxicity and efflux-mediated resistance. H...
BioPharm Services was first registered in 1998 and now employs more than 10 people in 2 offices in the US and UK. The company provides a broad spectrum of consultancy services covering all aspects of ...
R-Biopharm AG was founded in 1988 as a subsidiary of the company Röhm AG in Darmstadt. In 1991 R-Biopharm was acquired by Dr. Ralf Dreher through a management buy out. The main activity is the develo...
TTY Biopharm stands to innovate the industry,emerge anew from the ashes of self-kindled flames, and accept multi challenges, encourage enterprising ventures, and share its knowledge and information.
Biopharm is a multinational company founded in 1995 by a group of scientists and business executives with the vision of developing innovative natural nutraceuticals that are backed by solid scientific...
BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousa...
We have published hundreds of Cue Biopharm, Inc. news stories on BioPortfolio along with dozens of Cue Biopharm, Inc. Clinical Trials and PubMed Articles about Cue Biopharm, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cue Biopharm, Inc. Companies in our database. You can also find out about relevant Cue Biopharm, Inc. Drugs and Medications on this site too.